Dogwood Therapeutics, Inc. (DWTX)
NASDAQ: DWTX · Real-Time Price · USD
1.695
+0.005 (0.30%)
Jun 1, 2026, 3:00 PM EDT - Market open
Dogwood Therapeutics Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 13.23 | 6.52 | 14.85 | 3.32 | 7.03 | 14.01 |
Cash & Short-Term Investments | 13.23 | 6.52 | 14.85 | 3.32 | 7.03 | 14.01 |
Cash Growth | -24.58% | -56.06% | 347.64% | -52.82% | -49.81% | -52.99% |
Other Current Assets | 1.78 | 1.91 | 1.7 | 0.85 | 1.34 | 1.77 |
Total Current Assets | 15 | 8.43 | 16.54 | 4.17 | 8.37 | 15.78 |
Net Property, Plant & Equipment | 0.16 | 0.18 | 0.22 | - | - | - |
Other Intangible Assets | 67.83 | 68.99 | 65.71 | - | - | - |
Goodwill | 12.19 | 12.4 | 11.81 | - | - | - |
Other Long-Term Assets | 0.02 | 0.18 | 0.02 | - | - | - |
Total Assets | 95.21 | 90.17 | 94.31 | 4.17 | 8.37 | 15.78 |
Accounts Payable | 0.14 | 0.76 | 1.23 | 0.11 | 0.57 | 0.35 |
Accrued Expenses | 2.35 | 2.24 | 1.89 | 0.25 | 0.47 | 0.92 |
Current Portion of Leases | 0.06 | 0.06 | 0.05 | - | - | - |
Unearned Revenue | 0.01 | - | - | - | - | - |
Total Current Liabilities | 2.56 | 3.06 | 3.18 | 0.36 | 1.04 | 1.28 |
Long-Term Debt | - | - | 15.38 | - | - | - |
Long-Term Leases | 0.09 | 0.11 | 0.15 | - | - | - |
Other Long-Term Liabilities | 11.94 | 12.11 | 11.31 | - | - | - |
Total Long-Term Liabilities | 12.02 | 12.22 | 26.85 | - | - | - |
Total Liabilities | 14.58 | 15.27 | 30.03 | 0.36 | 1.04 | 1.28 |
Common Stock | 0 | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | -0.3 | -0.3 | -0.3 | -0.3 | - | - |
Additional Paid-in Capital | 195.7 | 183.86 | 67.86 | 65.58 | 63.5 | 58.43 |
Accumulated Other Comprehensive Income | -1.72 | -0.59 | -3.86 | - | - | - |
Retained Earnings | -113.06 | -108.08 | -73.82 | -61.47 | -56.17 | -43.93 |
Total Common Shareholders' Equity | 80.62 | 74.9 | -10.12 | 4.11 | 7.33 | 14.5 |
Minority Interest | - | - | 74.41 | - | - | - |
Shareholders' Equity | 80.62 | 74.9 | 64.28 | 4.11 | 7.33 | 14.5 |
Total Liabilities & Equity | 95.21 | 90.17 | 94.31 | 4.17 | 8.37 | 15.78 |
Total Debt | 0.14 | 0.16 | 15.59 | 0 | 0 | 0 |
Net Cash (Debt) | 13.08 | 6.36 | -0.74 | 3.32 | 7.03 | 14.01 |
Net Cash Growth | 105.64% | - | - | -52.82% | -49.81% | -52.99% |
Net Cash Per Share | 1.01 | 1.28 | -0.72 | 4.42 | 15.88 | 42.05 |
Book Value | 80.62 | 74.9 | -10.12 | 4.11 | 7.33 | 14.5 |
Book Value Per Share | 6.21 | 15.05 | -9.85 | 5.47 | 16.55 | 43.52 |
Tangible Book Value | 0.6 | -6.49 | -87.65 | 4.11 | 7.33 | 14.5 |
Tangible Book Value Per Share | 0.05 | -1.30 | -85.28 | 5.47 | 16.55 | 43.52 |